Akinori Miyashita

This study identifies GPR34 as a regulator of microglial amyloid β fibril uptake, showing that its agonist enhances fibril clearance and that its expression declines with age and AD progression.

This study performs APOE-stratified GWAS to uncover genetic mechanisms underlying Alzheimer's disease risk and response to therapies.

The paper identifies APOE rare missense variants in the Japanese population and finds two variants associated with protective effects against Alzheimer's disease.

This paper evaluates the polygenic risk score for Alzheimer's disease in Japanese individuals, showing its utility despite genetic differences from European populations.

The paper identifies RAC1 as a key gene in Alzheimer's disease progression through a protein domain network analysis and validates its role using Drosophila models and miRNA regulation.

The paper identifies enhancer variants linked to Alzheimer's disease that influence gene expression through chromatin looping mechanisms.